The bone marrow side of axial spondyloarthritis

Nat Rev Rheumatol. 2023 Aug;19(8):519-532. doi: 10.1038/s41584-023-00986-6. Epub 2023 Jul 5.

Abstract

Spondyloarthritis (SpA) is characterized by the infiltration of innate and adaptive immune cells into entheses and bone marrow. Molecular, cellular and imaging evidence demonstrates the presence of bone marrow inflammation, a hallmark of SpA. In the spine and the peripheral joints, bone marrow is critically involved in the pathogenesis of SpA. Evidence suggests that bone marrow inflammation is associated with enthesitis and that there are roles for mechano-inflammation and intestinal inflammation in bone marrow involvement in SpA. Specific cell types (including mesenchymal stem cells, innate lymphoid cells and γδ T cells) and mediators (Toll-like receptors and cytokines such as TNF, IL-17A, IL-22, IL-23, GM-CSF and TGFβ) are involved in these processes. Using this evidence to demonstrate a bone marrow rather than an entheseal origin for SpA could change our understanding of the disease pathogenesis and the relevant therapeutic approach.

Publication types

  • Review

MeSH terms

  • Axial Spondyloarthritis*
  • Bone Marrow / metabolism
  • Bone Marrow / pathology
  • Humans
  • Immunity, Innate
  • Inflammation
  • Lymphocytes / pathology
  • Spondylarthritis*